Allison is at the forefront of reporting on emerging startups and their investors, while also co-hosting "The Readout Loud," a weekly podcast focused on biotechnology. She can be contacted on Signal at AllisonDeAngelis.01.
In recent developments, the major pharmaceutical companies responsible for the highly effective weight loss medications Wegovy and Mounjaro are hinting at diversifying their portfolios into other aesthetic domains, such as hair restoration and skincare.
In a significant step toward this goal, one of these corporations has chosen to invest in a burgeoning startup focused on creating a treatment for hair loss, which may also have applications in managing endometriosis.
On Wednesday, Absci, a biotech company, revealed it had secured $100 million in funding from a consortium led by Eli Lilly. Lilly contributed the largest portion, investing $40 million in exchange for equity in Absci, which is listed on the Nasdaq.



